` RADLY (Raia Drogasil SA) vs S&P 500 Comparison - Alpha Spread

RADLY
vs
S&P 500

Over the past 12 months, RADLY has outperformed S&P 500, delivering a return of +29% compared to the S&P 500's +16% growth.

Stocks Performance
RADLY vs S&P 500

Loading
RADLY
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
RADLY vs S&P 500

Loading
RADLY
S&P 500
Difference
www.alphaspread.com

Performance By Year
RADLY vs S&P 500

Loading
RADLY
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Raia Drogasil SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Raia Drogasil SA
Glance View

Market Cap
8.1B USD
Industry
Retail

Raia Drogasil SA, Brazil's pharmaceutical titan, stands as a testament to the transformative power of strategic mergers and innovative retail management. Born out of the merger of Drogasil and Droga Raia, two of Brazil's enduring pharmacy chains, the company today operates an extensive network of retail stores across the nation. This strategic merger in 2011 was not merely a consolidation of operations but a fusion of distinct corporate cultures and expertise, aimed at enhancing operational efficiencies and expanding market share. By leveraging economies of scale, Raia Drogasil has entrenched itself as a formidable force in Brazil's healthcare retail sector, boasting a strong presence in both high-density urban centers and emerging markets in Brazil. The company's business model is built on a robust mix of health and wellness products, encompassing everything from prescription medications to over-the-counter remedies and personal care items. Raia Drogasil has adeptly positioned itself to capitalize on Brazil's growing healthcare demands, thanks to its comprehensive product offerings and strategic store locations. Each store functions as both a destination for health-conscious consumers and a vital link in the greater logistical chain that ensures timely product availability. By intertwining brick-and-mortar retail with digital innovation, Raia Drogasil not only drives revenue through traditional sales channels but also through its dynamic e-commerce platform. This synergy allows the company to tap into the evolving preferences of tech-savvy consumers, thereby making Raia Drogasil a leader in seamlessly integrating shopping experiences that cater to modern customer expectations.

RADLY Intrinsic Value
3.87 USD
Overvaluation 19%
Intrinsic Value
Price
Back to Top